Skip to content

ALPHABIOTOXINE LABORATORY

Active
Private limited companyfounded 2016active for 10 yearsBarberie(MB) 15, 7911 Frasnes-lez-Anvaing, BelgiumKBO/BCE: BE 0654.859.074
Summary

ALPHABIOTOXINE LABORATORY has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €589 and a net result of €854. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 14% of 613 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Activity
Other research and development on natural sciences
NACE 72109
1 site
Size
€110,739total assets 2025
Equity
€589
Profit
€854
Turnover not published (micro format)
Financial health
90 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
2025 accounts filed 11 days late2 of 3 deeds summarised
Why 90raises riskEquity €589 (0.5% of total assets)lowers riskSize: total assets €110,739Liquidity: current ratio 0.80, cash €64,165Sector: Scientific research and development (NACE 72)Show the evidence

Checked score

Score 2025
90 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 47% of its sector peers (NACE 72, micro)
Financial strength · tick = 2024
Average
Solvency 26+1
equity 0.5% of total assets
Liquidity 50=
short-term debt 99.5% · cash 57.9%
Profitability 70-6
return on assets 0.8%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.3%▲ +0.1 percentage points vs 07-2026highest value 09-2026: 0.2%▼ -0.1 percentage points vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026lowest value
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro): better than 17% on solvency, 28% on liquidity, 44% on profitability and 97% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
lowers risk · Size: total assets €110,739
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.80, cash €64,165
NBB · annual accounts
raises risk · Equity €589 (0.5% of total assets)
NBB · annual accounts
lowers risk · Sector: Scientific research and development (NACE 72)
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 613 sector peers (2025).
NBB · sector comparison
Position among 613 sector peers
Solvency
better than 14%
← weakest strongest →
raises risk · 2025 accounts filed 11 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-08-2026, 11 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 9 filings
Deviation from the deadline
2025
11 days late
2024
1 day early
2023
16 days late
2022
11 days late
2021
23 days late
2020
9 days late
2019
129 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 28 days after the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 11 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Appointment: Rudy Fourmy (director)Gazette deed
  2. Annual accounts filedfinancial year 2025 · micro…
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Caution: Among the weakest 14% on equitysector median €113,303 · 614 companies €589 View
  • New directorlatest change 01-07-2026 · 2 in office 1 joined View
  • Total assets 20256 financial years filed €110,739 View

By topic

Financials

Financial year
2025
Total assets
€110,739
Profit
€854
Solvency
0.5%
Total assets▲ 1.7%
Net result
20182025
Go to Financials

Timeline

Events
14
Since
2018
Next accounts
by 31-07-2027
  1. 16-08-2024Annual accounts filed
  2. 05-04-2024Resignation: VIOLETTE Aude (manager)
  3. 31-12-2023Back to profit
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Other research and development on natural sciencesNACE 72109
Founded
20-05-2016
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about ALPHABIOTOXINE LABORATORY

What is the company number of ALPHABIOTOXINE LABORATORY?
0654.859.074. In Belgium the VAT number is the company number with BE in front: BE 0654.859.074.
Where is ALPHABIOTOXINE LABORATORY based?
The registered office is at Barberie(MB) 15, 7911 Frasnes-lez-Anvaing.Company details
What does ALPHABIOTOXINE LABORATORY do?
According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
What is the legal form of ALPHABIOTOXINE LABORATORY?
Private limited company (BV).
When was ALPHABIOTOXINE LABORATORY founded?
On 20-05-2016.
Is ALPHABIOTOXINE LABORATORY still active?
Yes, ALPHABIOTOXINE LABORATORY is an active enterprise in the KBO register.
What is the turnover of ALPHABIOTOXINE LABORATORY?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is ALPHABIOTOXINE LABORATORY profitable?
In financial year 2025, ALPHABIOTOXINE LABORATORY made a profit of €854.
Where can I find the annual accounts of ALPHABIOTOXINE LABORATORY?
ALPHABIOTOXINE LABORATORY filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ALPHABIOTOXINE LABORATORY due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to ALPHABIOTOXINE LABORATORY

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.